Müller-Oerlinghausen B - Search Results

1

Müller-Oerlinghausen B, Berghöfer A, Bauer M. Müller-Oerlinghausen B, et al. Lancet. 2002 Jan 19;359(9302):241-7. doi: 10.1016/S0140-6736(02)07450-0. Lancet. 2002. PMID: 11812578 Review.

2

The antisuicidal and mortality-reducing effect of lithium prophylaxis: consequences for guidelines in clinical psychiatry.

Müller-Oerlinghausen B, Berghöfer A, Ahrens B. Müller-Oerlinghausen B, et al. Can J Psychiatry. 2003 Aug;48(7):433-9. doi: 10.1177/070674370304800702. Can J Psychiatry. 2003. PMID: 12971012 Review.

3

Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.

Baethge C, Gruschka P, Berghöfer A, Bauer M, Müller-Oerlinghausen B, Bschor T, Smolka MN. Baethge C, et al. J Affect Disord. 2004 Apr;79(1-3):43-50. doi: 10.1016/S0165-0327(02)00354-3. J Affect Disord. 2004. PMID: 15023479

4

Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients.

Baethge C, Baldessarini RJ, Mathiske-Schmidt K, Hennen J, Berghöfer A, Müller-Oerlinghausen B, Bschor T, Adli M, Bauer M. Baethge C, et al. J Clin Psychiatry. 2005 Feb;66(2):174-82. doi: 10.4088/jcp.v66n0204. J Clin Psychiatry. 2005. PMID: 15705002 Review.

5

The impact of lithium long-term medication on suicidal behavior and mortality of bipolar patients.

Müller-Oerlinghausen B, Felber W, Berghöfer A, Lauterbach E, Ahrens B. Müller-Oerlinghausen B, et al. Arch Suicide Res. 2005;9(3):307-19. doi: 10.1080/13811110590929550. Arch Suicide Res. 2005. PMID: 16020173 Review.

6

Long-term effectiveness of lithium in bipolar disorder: a multicenter investigation of patients with typical and atypical features.

Berghöfer A, Alda M, Adli M, Baethge C, Bauer M, Bschor T, Glenn T, Grof P, Müller-Oerlinghausen B, Rybakowski J, Suwalska A, Pfennig A. Berghöfer A, et al. J Clin Psychiatry. 2008 Dec;69(12):1860-8. doi: 10.4088/jcp.v69n1203. Epub 2008 Nov 18. J Clin Psychiatry. 2008. PMID: 19026269 Clinical Trial.

7

Influence of atypical features on the quality of prophylactic effectiveness of long-term lithium treatment in bipolar disorders.

Pfennig A, Schlattmann P, Alda M, Grof P, Glenn T, Müller-Oerlinghausen B, Suwalska A, Rybakowski J, Willich SN, Bauer M, Berghöfer A. Pfennig A, et al. Bipolar Disord. 2010 Jun;12(4):390-6. doi: 10.1111/j.1399-5618.2010.00826.x. Bipolar Disord. 2010. PMID: 20636636

8

Is there a loss of efficacy of lithium in patients treated for over 20 years?

Berghöfer A, Müller-Oerlinghausen B. Berghöfer A, et al. Neuropsychobiology. 2000;42 Suppl 1:46-9. doi: 10.1159/000054853. Neuropsychobiology. 2000. PMID: 11093072 Clinical Trial.

9

Does prophylaxis-delay in bipolar disorder influence outcome? Results from a long-term study of 147 patients.

Baethge C, Smolka MN, Gruschka P, Berghöfer A, Schlattmann P, Bauer M, Altshuler L, Grof P, Müller-Oerlinghausen B. Baethge C, et al. Acta Psychiatr Scand. 2003 Apr;107(4):260-7. doi: 10.1034/j.1600-0447.2003.02057.x. Acta Psychiatr Scand. 2003. PMID: 12662248 Clinical Trial.

10

Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disorders.

Bauer M, Baur H, Berghöfer A, Ströhle A, Hellweg R, Müller-Oerlinghausen B, Baumgartner A. Bauer M, et al. J Affect Disord. 2002 Apr;68(2-3):285-94. doi: 10.1016/s0165-0327(00)00363-3. J Affect Disord. 2002. PMID: 12063156

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters